Loading...
Research Project
Untitled
Funder
Authors
Publications
Phenolic profile of wild fruits of Rosa canina SL. from Northeast Portugal
Publication . Guimarães, Rafaela; Barros, Lillian; Reis, Filipa S.; Dueñas, Montserrat; Carvalho, Ana Maria; Santos-Buelga, Celestino; Queiroz, Maria João R.P.; Ferreira, Isabel C.F.R.
Plant polyphenols are a wide group of secondary metabolites and are a common component of our diet.
Flavonoids represent the most common and widely distributed group of plant phenolics, and can be further
broken into classes including flavones, flavonols, flavanones, flavanols, anthocyanins and isoflavonoids.
Different classes of bioactive constituents are present in Rosa canina, including phenolic compounds. Rosa
canina fruits can be eaten raw as snacks and possess prophylactic and therapeutic activities against a wide
range of ailments, including the inflammatory disorders arthritis, rheumatism, gout, colds and gastrointestinal
disorders, which might be related with their phenolic composition. This study aimed to characterize the
phenolic compounds present in the above mentioned wild fruits. The analysis of phenolic compounds was
carried out by reversed-phase HPLC-DAD and the major phenolic compounds were identified by ESI-MS, in
order to establish the specific phenolic profile. Rosa canina presented different classes of flavonoids.
Flavones, flavonols and dihydroflavonols represented 5.50 mg/100 g dry weight, among which taxifolin, a
dihydroflavonol, was prominent (1.18 mg/100 g). Flavan-3-ols (i.e., catechins and proanthocyanidins) were
other relevant flavonoids found. (+)-Catechin was the most abundant flavan-3-ol found in the fruits (3.59
mg/100 g), whereas cyanidin 3-O-glucoside was the only anthocyanin detected (0.68 μg/100 g). The studied
fruits may have great potential for food industries as a source of colors and flavors, as well as bioactive
molecules such as phenolic compounds for dietary supplements or functional foods.
Comparative study of the phenolic profile and antioxidant properties of Chamaemelum nobile: infusion, decoction, and hydroalcoholic extract
Publication . Guimarães, Rafaela; Barros, Lillian; Dueñas, Montserrat; Carvalho, Ana Maria; Santos-Buelga, Celestino; Queiroz, Maria João R.P.; Ferreira, Isabel C.F.R.
This stud} aimed to determine the phenolic composition and to evaluate the antioxidant activity
o f different preparation' of Roman chamomile: infusion. decoction and methanol: water (80:20)
extract. The hydroalcoholic extract revealed the highest antioxidant activity in almost all the
performed assays (EC\ , ≤0.62 mg/ml. depending on the assay ). which was in agreement with
its highest total content in phenolic compounds. Otherwise. decoctions presented the lowest
antioxidant potential (EC50 ≤1.4S mg/mL. depending on the assay). The phenolic profile of the
different preparations was identical. varying only in the concentrations found. Phenolic acids
(caffooylquinic acids). flavonols (quercetin and kaempferol derivatives) and flavones (apigenin
and luteolin derivatives) were found in the three preparations. The most abundant compounds in
the infusion and hydroalcoholic ex tract we re 5-0 -caffeoylquinic acid and an apigenin
derivative. These. as also the other phenolic compounds, decreased significantly in the
decoction .
Wild Roman chamomile extracts and phenolic compounds: enzymatic assays and molecular modelling studies with VEGFR-2 tyrosine kinase
Publication . Guimarães, Rafaela; Calhelha, Ricardo C.; Froufe, Hugo J.C.; Abreu, Rui M.V.; Carvalho, Ana Maria; Queiroz, Maria João R.P.; Ferreira, Isabel C.F.R.
Angiogenesis is a process by which new blood vessels are formed from the pre-existing vasculature, and it is a key process that leads to tumour development. Some studies have recognized phenolic compounds as chemopreventive agents; flavonoids, in particular, seem to suppress the growth of tumor cells modifying the cell cycle. Herein, the antiangiogenic activity of Roman chamomile (Chamaemelum nobile L.) extracts (methanolic extract and infusion) and the main phenolic compounds present (apigenin, apigenin-7-O-glucoside, caffeic acid, chlorogenic acid, luteolin, and luteolin-7-O-glucoside) was evaluated through enzymatic assays using the tyrosine kinase intracellular domain of the Vascular Endothelium Growth Factor Receptor-2 (VEGFR-2), which is a transmembrane receptor expressed fundamentally in endothelial cells involved in angiogenesis, and molecular modelling studies. The methanolic extract showed a lower IC50 value (concentration that provided 50% of VEGFR-2 inhibition) than the infusion, 269 and 301 μg mL(-1), respectively. Regarding phenolic compounds, luteolin and apigenin showed the highest capacity to inhibit the phosphorylation of VEGFR-2, leading us to believe that these compounds are involved in the activity revealed by the methanolic extract.
Phytochemicals and bioactivity in wild German and Roman chamomiles infusions
Publication . Guimarães, Rafaela; Barros, Lillian; Calhelha, Ricardo C.; Carvalho, Ana Maria; Queiroz, Maria João R.P.; Ferreira, Isabel C.F.R.
Natural matrices represent a rich source of biologically active compounds and are an example of
molecular diversity, with recognized potential in drug discovery. In the present work, the infusions
of Matricaria recutita L. (German chamomile) and Chamaemelum nobile L. (Roman chamomile)
were submitted to an analysis of phenolic compounds and evaluation of bioactivity. Phenolic
compounds were characterized by reversed-phase high performance liquid chromatography
coupled to diode array detection and mass spectrometry with electron spray ionization (HPLCDAD/
ESI-MS). The bioactivity of the samples was tested in different human tumour cell lines
(breast- MCF-7, lung- NCI-H460, colon- HCT -15, cervical- He l a and hepatocellular- HepG2
carcinomas}, and the hepatotoxicity was evaluated using a porcine liver primary cell culture (nontumour
cells, PLP2) [1 ,2]. The major compounds found were luteolin 0-acylhexoside in German
chamomile, and 5-0-caffeoylquinic acid and an apigenin derivative in Roman chamomile. The
highest potential antioxidant activity was showed by German chamomile in all the in vitro assays.
Both the infusions showed inhibitory activity of the growth of HCT -15 and He la cell lines, without
hepatotoxicity (GI 50>400 μg/ml). Nevertheless, Roman chamomile infusion presented the highest
inhibitory activity for all the cell lines (GI50<168 μg/ml ). Overall, infusions of both chamomiles
contain important phytochemicals with bioactive properties to be explored in medicinal, food, and
cosmetic industries.
Inhibition of the VEGFR-2 tyrosine kinase domain by witd Roman chamomile extracts and phenolic compounds
Publication . Guimarães, Rafaela; Calhelha, Ricardo C.; Froufe, Hugo J.C.; Abreu, Rui M.V.; Carvalho, Ana Maria; Ferreira, Isabel C.F.R.; Queiroz, Maria João R.P.
Angiogenesis results from new blood vessels growing excessively (e. g. câncer). The Vascular
Endothelial Growth Factor (VEGF) is secreted by the tumor cells and plays a crucial role in
angiogenesis; low oxygen tension dramatically induces the expression of this major angiogenic
factor that when linked to the transmembrane tyrosine kinase receptor VEGFR-2, which is
present in endothelial cells, signalizes for the proliferation of these cells towards the tumor.
Treatments using small molecules with anti-tyrosine kinase activity (e. g., sorafenib) can block
angiogenic signalling, reduce blood tumoral irrigation, and improve chemotherapy distribution
[1]. Some studies recognized phenolic compounds as chemopreventive agents, especially
flavonoids. Other plant-derived anticancer drugs (e. g. Taxol) proved to be anti-angiogenic. In
traditional Chinese medicine, many herbs are used in the treatment of angiogenic diseases
such as chronic wounds and rheumatoid arthritis [2]. Furthermore, it has been reported that
drinking of green tea could inhibit VEGF-induced angiogenesis in vivo [3]. In the present work,
the anti-angiogenic activity of Roman chamomile (Chamaemelum nobile L.) extracts (methanolic
extract and infusion) and main phenolic compounds (apigenin, apigenin-7-O-glucoside, caffeic
acid, chlorogenic acid, luteolin, luteolin-7-O-glucoside) was evaluated through an enzymatic
assay using the VEGFR-2 tyrosine kinase domain. To better understand the inhibition
phosphorylation mechanism of the tyrosine kinase receptor by luteolin, apigenin and apigenin-7-
0-glucoside, docking studies were performed. The methanolic extract showed higher
phosphorylation inhibition than the infusion (IC50 values of 269 and 301 μg/mL, respectively).
Regarding phenolic compounds, luteolin (IC50 2.10 μM) and apigenin (IC50 4.78 μM) were the
most potent in inhibiting VEGFR-2 phosphorylation, leading us to believe that these compounds
are involved in the anti-angiogenic activity revealed by the methanolic extract.
Organizational Units
Description
Keywords
Contributors
Funders
Funding agency
Fundação para a Ciência e a Tecnologia
Funding programme
SFRH
Funding Award Number
SFRH/BD/78307/2011